A.R.T. Advisors’s NanoViricides NNVC Stock Holding History

A.R.T. Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-873	Closed	-$14K	–	1658
2018 Q1	$14K	Buy	873 +349	+67%	+$6.45K	﹤0.01%	1449
2017 Q4	$9K	Buy	+524	New	+$10.7K	﹤0.01%	1323
2016 Q3	–	Sell	-2,647	Closed	-$84K	–	995
2016 Q2	$84K	Buy	+2,647	New	+$96.6K	﹤0.01%	1225
2016 Q1	–	Sell	-869	Closed	-$20K	–	1563
2015 Q4	$20K	Buy	+869	New	+$20.8K	﹤0.01%	1411

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PTB

Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

A.R.T. Advisors's NNVC Position: Q2 2018 in Review

A.R.T. Advisors sold out of NanoViricides (NNVC) in Q2 2018, closing a stake of 873 shares — an estimated $14K sold.

A.R.T. Advisors first reported a position in NNVC in Q4 2015 and held it in 4 quarters. The position peaked at $84K in Q2 2016. 42 funds tracked by Wall St. Rank hold NNVC as of Q2 2018.

A.R.T. Advisors reported no remaining NanoViricides position as of Q2 2018 after selling out during the quarter.
A.R.T. Advisors sold 873 NanoViricides shares in Q2 2018, an estimated $14K.
A.R.T. Advisors first reported a position in NanoViricides in Q4 2015 and held it in 4 quarters.
A.R.T. Advisors's NanoViricides position peaked at $84K in Q2 2016.
42 funds tracked by Wall St. Rank held NanoViricides as of Q2 2018.

Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.